Brain cholesterol homeostasis in Wilson disease

被引:6
作者
Cacciatore, Stefano [1 ,2 ]
Tenori, Leonardo [3 ]
机构
[1] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Rovira & Virgili, Spanish Biomed Res Ctr Diabet & Associated Metab, E-43007 Tarragona, Spain
[3] FiorGen Fdn, I-50019 Sesto Fiorentino, Italy
关键词
CENTRAL-NERVOUS-SYSTEM; GENE KNOCKOUT MICE; ALZHEIMERS-DISEASE; COPPER ACCUMULATION; PROTEIN OXIDATION; IN-VITRO; TURNOVER; METABOLISM; 24S-HYDROXYCHOLESTEROL; MECHANISM;
D O I
10.1016/j.mehy.2013.10.018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Wilson disease (WD) is an autosomal recessive inherited disorder of copper (Cu) metabolism, resulting in pathological accumulation of Cu in many organs and tissues, predominantly in the liver and brain. There clearly is a close and complex relationship between Cu and the cholesterol's metabolic pathway; therefore any theory about the cholesterol metabolism in the brain of patients with WD must take it into account. The hypothesis presented in this paper is that the imbalance in cerebral copper homeostasis caused by WD may plays a key role in the derangement of the cholesterol homeostasis in the brain, and thus promoting the observed WD related neurological disorders. Crown Copyright (C) 2013 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1127 / 1129
页数:3
相关论文
共 35 条
[1]   Wilson's disease [J].
Ala, Aftab ;
Walker, Ann P. ;
Ashkan, Keyoumars ;
Dooley, James S. ;
Schilsky, Michael L. .
LANCET, 2007, 369 (9559) :397-408
[2]   Lipid raft microdomains and neurotransmitter signalling [J].
Allen, John A. ;
Halverson-Tamboli, Robyn A. ;
Rasenick, Mark M. .
NATURE REVIEWS NEUROSCIENCE, 2007, 8 (02) :128-140
[3]   Sensitivity to Lysosome-Dependent Cell Death Is Directly Regulated by Lysosomal Cholesterol Content [J].
Appelqvist, Hanna ;
Sandin, Linnea ;
Bjornstrom, Karin ;
Saftig, Paul ;
Garner, Brett ;
Ollinger, Karin ;
Kagedal, Katarina .
PLOS ONE, 2012, 7 (11)
[4]   Pharmacokinetics, excretion, and mass balance of 14C after administration of 14C-cholesterol-labeled AmBisome to healthy volunteers [J].
Bekersky, I ;
Fielding, RM ;
Dressler, DE ;
Kline, S ;
Buell, DN ;
Walsh, TJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (09) :963-971
[5]   Brain cholesterol:: Long secret life behind a barrier [J].
Björkhem, I ;
Meaney, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) :806-815
[6]  
Björkhem I, 1998, J LIPID RES, V39, P1594
[7]   Importance of a novel oxidative mechanism for elimination of brain cholesterol - Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with O-18(2) techniques in vivo and in vitro [J].
Bjorkhem, I ;
Lutjohann, D ;
Breuer, O ;
Sakinis, A ;
Wennmalm, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30178-30184
[8]   Genetic connections between neurological disorders and cholesterol metabolism [J].
Bjorkhem, Ingemar ;
Leoni, Valerio ;
Meaney, Steve .
JOURNAL OF LIPID RESEARCH, 2010, 51 (09) :2489-2503
[9]   Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation [J].
Buiakova, OI ;
Xu, J ;
Lutsenko, S ;
Zeitlin, S ;
Das, K ;
Das, S ;
Ross, BM ;
Mekios, C ;
Scheinberg, IH ;
Gilliam, TC .
HUMAN MOLECULAR GENETICS, 1999, 8 (09) :1665-1671
[10]   THE WILSON DISEASE GENE IS A PUTATIVE COPPER TRANSPORTING P-TYPE ATPASE SIMILAR TO THE MENKES GENE [J].
BULL, PC ;
THOMAS, GR ;
ROMMENS, JM ;
FORBES, JR ;
COX, DW .
NATURE GENETICS, 1993, 5 (04) :327-337